Fingerprint
Dive into the research topics of 'Phase II study of etoposide, ifosfamide, and mitoxantrone for the treatment of resistant adult acute lymphoblastic leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of etoposide, ifosfamide, and mitoxantrone for the treatment of resistant adult acute lymphoblastic leukemia
Gary Schiller, Myung Lee, Mary Territo, James Gajewski, Stephen Nimer
Research output: Contribution to journal › Article › peer-review
12
Scopus
citations